Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Repel proved effective in preclinical studies

Aug. 23, 1996

Genzyme's Seprafilm approved by FDA

Aug. 23, 1996

Kanebo and Ontogen to codevelop cell adhesion factor inhibitor

Aug. 23, 1996

Dusa completes phase IIb for ALA PDT

Aug. 23, 1996

Dyad granted U.S. patent for oligonucleotides

Aug. 23, 1996

Protein Polymer Technologies and Ethicon sign R&D agreement

Aug. 23, 1996

Microsponge retinol system to be codeveloped by APS and Avon

Aug. 16, 1996

Phytopharm files for U.K. marketing approval of Zemaphyte

Aug. 16, 1996

Psoriasin role in psoriasis pathology under scrutiny

Aug. 16, 1996

FK-506: A safe and effective atopic dermatitis treatment

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026